Published in PLoS One on November 30, 2016
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro. PLoS One (2017) 0.75
Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev (2002) 17.58
Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev (2007) 15.66
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol (2006) 10.15
Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol (2001) 6.98
Candida biofilms and their role in infection. Trends Microbiol (2003) 5.13
Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science (1999) 4.00
Candida biofilms: an update. Eukaryot Cell (2005) 3.58
Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol (2009) 3.20
Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis (2002) 3.04
Growth of Candida albicans hyphae. Nat Rev Microbiol (2011) 3.02
Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol (2006) 2.76
Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev (2007) 2.71
Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta (1992) 2.63
The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett (2002) 2.50
Ras links cellular morphogenesis to virulence by regulation of the MAP kinase and cAMP signalling pathways in the pathogenic fungus Candida albicans. Mol Microbiol (2001) 2.32
Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell (2006) 2.21
A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog (2012) 1.88
Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin Infect Dis (2005) 1.87
Antimicrobial peptides stage a comeback. Nat Biotechnol (2013) 1.73
The basic helix-loop-helix transcription factor Cph2 regulates hyphal development in Candida albicans partly via TEC1. Mol Cell Biol (2001) 1.52
Characterization of mucosal Candida albicans biofilms. PLoS One (2009) 1.51
Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect (2009) 1.26
Adherence mechanisms in human pathogenic fungi. Med Mycol (2008) 1.16
Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect Immun (2001) 1.13
The Ras/cAMP/PKA signaling pathway and virulence in Candida albicans. Future Microbiol (2009) 1.13
Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS One (2011) 1.08
Roles of Zinc-responsive transcription factor Csr1 in filamentous growth of the pathogenic Yeast Candida albicans. J Microbiol Biotechnol (2008) 1.07
Structure and biological actions of lactoferrin. J Mammary Gland Biol Neoplasia (1996) 1.01
Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin. Antimicrob Agents Chemother (2002) 1.00
Candida albicans biofilms: building a heterogeneous, drug-tolerant environment. Curr Opin Microbiol (2013) 1.00
Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11). BMC Med (2009) 0.94
Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection. J Infect Dis (2007) 0.91
Histatin 5-spermidine conjugates have enhanced fungicidal activity and efficacy as a topical therapeutic for oral candidiasis. Antimicrob Agents Chemother (2013) 0.91
Mini-review: Antimicrobial peptides and enzymes as promising candidates to functionalize biomaterial surfaces. Biofouling (2014) 0.86
Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans. PLoS One (2015) 0.85
Effect of tetrandrine against Candida albicans biofilms. PLoS One (2013) 0.84
C. albicans growth, transition, biofilm formation, and gene expression modulation by antimicrobial decapeptide KSL-W. BMC Microbiol (2013) 0.83
Covalent immobilization of hLf1-11 peptide on a titanium surface reduces bacterial adhesion and biofilm formation. Acta Biomater (2014) 0.82
The antimicrobial peptide hLF1-11 drives monocyte-dendritic cell differentiation toward dendritic cells that promote antifungal responses and enhance Th17 polarization. J Innate Immun (2012) 0.81
Induction of lactoferrin gene expression by innate immune stimuli in mouse mammary epithelial HC-11 cells. Biochimie (2008) 0.80
Antifungal Activity of 14-Helical β-Peptides against Planktonic Cells and Biofilms of Candida Species. Pharmaceuticals (Basel) (2015) 0.80
The human lactoferrin-derived peptide hLF1-11 primes monocytes for an enhanced TLR-mediated immune response. Biometals (2010) 0.78
Synergistic Activity of the Plant Defensin HsAFP1 and Caspofungin against Candida albicans Biofilms and Planktonic Cultures. PLoS One (2015) 0.78
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Oncotarget (2016) 0.76
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors. Sci Rep (2016) 0.75
Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains. Eur J Clin Microbiol Infect Dis (2017) 0.75
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro. PLoS One (2017) 0.75
Fatal fungemia by biofilm-producing in a liver transplant candidate. Infez Med (2021) 0.75
Recent advances in the microbiological diagnosis of bloodstream infections. Crit Rev Microbiol (2017) 0.75
The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters. Front Microbiol (2017) 0.75